Pathogenesis and Therapeutic Advances in Heart Failure with Preserved Ejection Fraction

Area of Science:

• Cardiology
• Molecular Biology
• Pathophysiology

Background:

• Heart failure with preserved ejection fraction (HFpEF) is the predominant type of heart failure.
• Research is shifting towards molecular mechanisms underlying HFpEF.
• Key areas of focus include inflammation, oxidative stress, metabolic dysregulation, and cardiac compliance issues.

Purpose of the Study:

• To review recent advancements in understanding HFpEF pathogenesis.
• To summarize emerging therapeutic strategies for HFpEF.
• To provide insights for future diagnostic and management approaches.

Main Methods:

• Literature review of recent studies on HFpEF.
• Synthesis of information on molecular mechanisms.
• Analysis of novel treatment strategies.

Main Results:

• HFpEF involves complex molecular pathways beyond traditional pathophysiology.
• Inflammation, oxidative stress, and metabolic dysregulation are critical.
• Impaired cardiac compliance, including hypertrophy and fibrosis, is a hallmark.

Conclusions:

• Novel therapeutic targets are emerging based on molecular insights.
• Integrated approaches combining conventional and novel therapies are needed.
• Further research is crucial for improved HFpEF diagnosis and management.